Blood Test Predicts Chemotherapy Benefit in Colorectal Cancer, Study Finds
A blood test may help identify which patients with colorectal cancer that has spread to the liver are…
The clinical utility of molecular residual disease testing in early-stage breast cancer
Molecular residual disease (MRD) testing using circulating tumor DNA assays shows promise in early-stage breast cancer by detecting…
ctDNA could aid surgical de-escalation in older ER+ breast cancer patients
Original story from UPMC For women age 70 and over with a common form of breast cancer, determining…
Blood test predicts advanced breast cancer treatment response before therapy begins
Original story from The Institute of Cancer Research A blood test can predict how well patients with advanced…